Annexin Pharmaceuticals AB (OSTO:ANNX) Buyback Yield %: -12.14 (As of Jul. 11, 2026)


OSTO:ANNX Annexin Pharmaceuticals AB OSTO:ANNX
23 GF Score
Price kr12.90
! 1 Warning Sign
View Full Analysis

What is Annexin Pharmaceuticals AB Buyback Yield %?

Annexin Pharmaceuticals AB OSTO:ANNX -1.90% 23 Buyback Yield % is -12.14 as of Jul. 11, 2026. GuruFocus rates OSTO:ANNX with a GF Score™ of 23/100. The stock has 1 warning sign investors should review. Among 742 Biotechnology companies, Annexin Pharmaceuticals AB ranks worse than 55.93% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Annexin Pharmaceuticals AB's current buyback yield was -12.14%.

Annexin Pharmaceuticals AB Buyback Yield % Related Terms

Annexin Pharmaceuticals AB Buyback Yield % Historical Data

* Premium members only.

The historical data trend for Annexin Pharmaceuticals AB's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Annexin Pharmaceuticals AB Buyback Yield % Chart

Annexin Pharmaceuticals AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Buyback Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -48.58 -14.98 -29.41 -17.36 -35.75

Annexin Pharmaceuticals AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -33.13 -26.61 -25.28 -35.75 -12.23

OSTO:ANNX vs VRTX, REGN, ALNY: Buyback Yield % Comparison

For the Biotechnology subindustry, Annexin Pharmaceuticals AB's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Annexin Pharmaceuticals AB Buyback Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Annexin Pharmaceuticals AB's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Annexin Pharmaceuticals AB's Buyback Yield % falls into.


OSTO:ANNX
23GF Score
Annexin Pharmaceuticals AB OSTO:ANNX
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Annexin Pharmaceuticals AB Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Annexin Pharmaceuticals AB's Buyback Yield for the fiscal year that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 49.973) / 139.77433486
=-35.75%

Annexin Pharmaceuticals AB's annualized Buyback Yield for the quarter that ended in Mar. 2026 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 11.31) / 92.476957692
=-12.23%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of -12.14 mean?
Annexin Pharmaceuticals AB (OSTO:ANNX) has a Buyback Yield % of -12.14 as of Jul. 11, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Annexin Pharmaceuticals AB and its competitors. According to the industry distribution chart, Annexin Pharmaceuticals AB ranks #415 out of 742 companies in the Biotechnology industry, placing it in the top 55.9%.
Is Annexin Pharmaceuticals AB's Buyback Yield % too high?
Annexin Pharmaceuticals AB's current Buyback Yield % is -12.14. Based on the distribution chart, Annexin Pharmaceuticals AB ranks #415 out of 742 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Annexin Pharmaceuticals AB has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Annexin Pharmaceuticals AB's Buyback Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Annexin Pharmaceuticals AB ranks #415 out of 742 companies for Buyback Yield %. This places Annexin Pharmaceuticals AB in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Biotechnology company?
A good Buyback Yield % depends on the Biotechnology industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Annexin Pharmaceuticals AB and its competitors. Annexin Pharmaceuticals AB's current Buyback Yield % is -12.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Annexin Pharmaceuticals AB stock overvalued right now?
Annexin Pharmaceuticals AB (OSTO:ANNX) has a current Buyback Yield % of -12.14. The current Buyback Yield % is -12.14. Annexin Pharmaceuticals AB's overall GF Score™ is 23/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Annexin Pharmaceuticals AB (OSTO:ANNX), the current Buyback Yield % is -12.14 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Annexin Pharmaceuticals AB Business Description

Other Exchanges Q910:Germany
Address Kammakargatan 48, Stockholm, SWE, 111 60
Annexin Pharmaceuticals AB is a biotechnology company. It is developing biological drug candidate ANXV, a recombinant human protein Annexin A5 for treatment of various cardiovascular diseases. The company also focuses on development of ANXV for the treatment of retinal vein occlusion.
23GF Score

Get the complete analysis for OSTO:ANNX

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr12.90
Price